Observed mean change in weight over time from baseline to 40 weeks (lb)1,6
Line graph depicting observed mean change in weight over time from baseline to 40 weeks. At week 0, there were 470, 469, 469, and 468 adult patients in the Mounjaro 5 mg, 10 mg, 15 mg, and Ozempic 1 mg treatment groups, respectively. The observed mean change in weight at 40 weeks was -17.6 lb, -21.1 lb, -25.5 lb, and -13.3 lb for Mounjaro 5 mg (n=450), 10 mg (n=443), 15 mg (n=448), and Ozempic 1 mg (n=444), respectively. The least-squares mean change in weight at 40 weeks with multiple imputation was -16.8 lb, -20.5 lb, -24.7 lb, and -12.6 lb for Mounjaro 5 mg (n=470), 10 mg (n=469), 15 mg (n=469), and Ozempic 1 mg (n=468), respectively. The mean baseline weights were 203.9 Ib, 209.1 Ib, 206.8 Ib, and 206.6 Ib in the Mounjaro 5 mg, 10 mg, 15 mg, and Ozempic 1 mg treatment groups, respectively.